House Bill 1238
2021-2022 Regular Session
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
Co-Sponsorship Memo
Prime Sponsor
Representative Christopher Quinn
R House District 168
Co-Sponsors
Rep. Maureen Madden
D House District 115
Rep. David Zimmerman
R House District 99
Rep. David Delloso
D House District 162
Rep. Scott Conklin
D House District 77
Bill Status & History
Last Action: Referred to Judiciary, April 20, 2021
House
H
S
Printers Numbers
Votes
There are no votes available.
Committee Meetings
There are no committee meetings available.
Statute References
This bill amends the act of April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The. Other bills amending the same statute are listed below.
Rep. Carol Hill-Evans
D House District 95
Rep. Sara Innamorato
D House District 21
Only the first 5 bills are included here. Looking for more?
View all legislation amending the act of
April 14, 1972 (P.L.0233, No.64), known as the Controlled Substance, Drug, Device And Cosmetic Act, The
House Bill 1238
2021-2022 Regular Session
Sponsors
QUINN, MADDEN, ZIMMERMAN, DELLOSO, CONKLIN
Short Title
An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose response immunity.
Memo Subject
Good Samaritan Immunity (Former HB137)
Actions
| 1302 | Referred to JUDICIARY, April 20, 2021 |
Generated 05/16/2025 04:58 AM